Open-label Pimavanserin 34mg at Bedtime for 6 Weeks for Insomnia in Veterans With Post-traumatic Stress Disorder: Proof of Concept Study
Latest Information Update: 28 Mar 2023
At a glance
- Drugs Pimavanserin (Primary)
- Indications Insomnia; Post-traumatic stress disorders
- Focus Proof of concept; Therapeutic Use
- 23 Mar 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 14 Jun 2022 Planned End Date changed from 15 Sep 2022 to 15 Dec 2023.
- 14 Jun 2022 Planned primary completion date changed from 15 Sep 2022 to 15 Dec 2023.